Home > News > Capsulution is Starting In-vivo Tests at Charité
September 18th, 2006
Capsulution is Starting In-vivo Tests at Charité
Abstract:
The nanotechnology company Capsulution NanoScience AG (Berlin, Germany) has begun with pre-clinical in-vivo tests of innovative formulations of a hormone compound for tumor therapy.
Source:
pressebox.de
Related Links |
Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||